Charles Schwab Investment Management Inc Talis Biomedical Corp Transaction History

Charles Schwab Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.44 $25,372 - $45,106	-31,324 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.3 - $4.19 $7,007 - $22,584	-5,390 Reduced 14.68%	31,324 $45,000
Q3 2021 Nov 16, 2021	SELL	$6.02 - $12.46 $356,877 - $738,653	-59,282 Reduced 61.75%	36,714 $230,000
Q2 2021 Aug 16, 2021	BUY	$9.62 - $14.56 $22,481 - $34,026	2,337 Added 2.5%	95,996 $1.06 Million
Q1 2021 May 17, 2021	BUY	$11.2 - $27.8 $1.05 Million - $2.6 Million	93,659 New	93,659 $1.2 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.9M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.